Pages that link to "Q36840289"

The following pages link to C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis (Q36840289):

Displaying 42 items.

• Dinosaurs and ancient civilizations: reflections on the treatment of cancer (Q24628746) (← links)
• Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer (Q26742062) (← links)
• Cellular Plasticity in Prostate Cancer Bone Metastasis (Q28085013) (← links)
• Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis (Q30440601) (← links)
• Neoplasia: the second decade (Q30484000) (← links)
• c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies. (Q33677797) (← links)
• Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma (Q34072863) (← links)
• Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth (Q34353130) (← links)
• c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands. (Q34478359) (← links)
• Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling (Q35036800) (← links)
• CD117⁺ cells in the circulation are predictive of advanced prostate cancer (Q35176469) (← links)
• The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches (Q35499809) (← links)
• Normal peripheral prostate stromal cells stimulate prostate cancer development: roles of c-kit signal (Q35662979) (← links)
• Human Stromal Cells in the Peripheral Zone of the Prostate Promote Tumorigenesis of Prostatic Cancer Stem Cells through Up-regulation of C-Kit Expression (Q35856865) (← links)
• Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients (Q35956586) (← links)
• Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer (Q35985440) (← links)
• Interleukin-1 beta induces the expression and production of stem cell factor by epithelial cells: crucial involvement of the PI-3K/mTOR pathway and HIF-1 transcription complex. (Q36459104) (← links)
• A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer. (Q36462972) (← links)
• Tie-2 regulates the stemness and metastatic properties of prostate cancer cells. (Q36771868) (← links)
• Mast cell regulation of the immune response (Q36834357) (← links)
• CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome (Q37016233) (← links)
• The War on Cancer rages on. (Q37478602) (← links)
• From pathogenesis to prevention of castration resistant prostate cancer (Q37598730) (← links)
• Pathogenesis of osteoblastic bone metastases from prostate cancer (Q37682761) (← links)
• Targeting Tyrosine Kinases and Autophagy in Prostate Cancer (Q37847052) (← links)
• The SCF/c-KIT system in the male: Survival strategies in fertility and cancer (Q38264052) (← links)
• Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer (Q38897955) (← links)
• Mir-152 inhibits cell proliferation and colony formation of CD133( ) liver cancer stem cells by targeting KIT. (Q38948202) (← links)
• Prognostic role of microRNA-221 in various human malignant neoplasms: a meta-analysis of 20 related studies (Q39261238) (← links)
• Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines (Q39410915) (← links)
• Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis (Q39424549) (← links)
• Regulation of FGF‐2 by an endogenous antisense RNA: Effects on cell adhesion and cell‐cycle progression (Q39644344) (← links)
• Androgen deprivation and stem cell markers in prostate cancers. (Q39744887) (← links)
• Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate. (Q47327428) (← links)
• Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis. (Q47864550) (← links)
• Mechanisms of receptor tyrosine kinase activation in cancer (Q49888000) (← links)
• CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance. (Q53703721) (← links)
• Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease. (Q54387640) (← links)
• Expression of AMHR2 and C-KIT in cervical lesions in Uyghur Women of Xinjiang, China. (Q54977544) (← links)
• RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid Biopsies (Q57107354) (← links)
• Contributions of Thyroid Hormone to Cancer Metastasis (Q58717087) (← links)
• Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells (Q86905514) (← links)